The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global arachidonic acid market size reached US$ 241.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 339.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6% during 2022-2027.
Arachidonic acid is a long-chain essential fatty acid used by the human body to synthesize unsaturated carboxylic acids. It is usually consumed in small quantities and is extracted from various food sources, such as poultry, eggs, fish and animal meat. It can also be obtained from mosses and algae. It is commonly available in dry and liquid forms and is added to various food products, dietary supplements, infant formula and pharmaceuticals. Arachidonic acid is combined with docosahexaenoic acid (DHA) to stimulate growth and development in children and send signals to the cell membranes to initiate adaptive changes in case of muscle damage. It is administered through tablets, injections and syrups to meet the nutritional requirements of both adults and children.
The increasing consciousness regarding child nutrition among the masses is one of the key factors creating driving the market growth. Arachidonic acid is added to women's nutrition and baby food products to promote the development of eyesight, immune response, memory and cell membranes in the body. Moreover, the rising incidence of lifestyle-related disorders leading to the increasing demand for dietary supplements is providing a thrust to the market growth. Consumer preference is rapidly shifting toward premium-quality oil-based nutritional supplements containing essential fatty acids to meet the daily nutritional requirements and lead a healthy lifestyle. In line with this, the increasing demand for sports supplements among the masses is also contributing to the growth of the market. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the increasing consumer awareness regarding the benefits of maintaining adequate nutrition in their diet, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global arachidonic acid market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on source, form and end user.
Breakup by Source:
Breakup by Form:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Bio-Techne Corporation, Cargill Incorporated, Cayman Chemical Company, Croda International Plc, Kingdomway Nutrition Inc., Koninklijke DSM N.V. and Merck KGaA.
|Base Year of the Analysis||2021|
|Segment Coverage||Source, Form, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||BASF SE, Bio-Techne Corporation, Cargill Incorporated, Cayman Chemical Company, Croda International Plc, Kingdomway Nutrition Inc., Koninklijke DSM N.V. and Merck KGaA|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at